Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Read more about Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.
Another drug in the armamentarium to combat hepatitis B virus in adolescents. Read more about Another drug in the armamentarium to combat hepatitis B virus in adolescents.
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Read more about Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Read more about Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.
A ZFN/piggyBac step closer to autologous liver cell therapy. Read more about A ZFN/piggyBac step closer to autologous liver cell therapy.
Ethnicity and nonalcoholic fatty liver disease. Read more about Ethnicity and nonalcoholic fatty liver disease.
Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Read more about Stem cells in liver diseases and cancer: recent advances on the path to new therapies.
Racial differences in hepatitis C treatment eligibility. Read more about Racial differences in hepatitis C treatment eligibility.
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Read more about Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.
